Skip to content

Welcome to the
CF AMR Syndicate

PPI 2022 GOLD badge

Who we are

In 2019 Medicines Discovery Catapult joined forces with Cystic Fibrosis Trust to form the Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR). The Syndicate recently expanded welcoming LifeArc in a tripartite managing partnership. The CF Syndicate in AMR is a cross-sector initiative which brings together leading experts in CF/AMR from industry, academia and the clinic together with people with CF. 

AMR Syndicate HP-04
AMR Syndicate HP-05

Join our Network

The CF AMR Network will facilitate collaboration and knowledge exchange in CF infection research.

Our aim is to create a diverse cross-sector collaborative network, with the expertise and drive required to drive and accelerate CF antimicrobial development.

If you have a question that you can’t find the answer to